| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,958 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brown Rodger A |
Vice President |
• • – |
2013-03-13 |
4 |
D |
$3.16 |
$51,173 |
D/D |
(16,194) |
123,027 |
|
- |
|
| Brown Rodger A |
Vice President |
• • – |
2013-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
139,221 |
|
- |
|
| Larson Brent L |
SVP, CFO, Treas & Secy |
• • – |
2013-03-13 |
4 |
D |
$3.16 |
$135,314 |
D/D |
(42,821) |
282,304 |
|
- |
|
| Larson Brent L |
SVP, CFO, Treas & Secy |
• • – |
2013-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
325,125 |
|
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2013-03-13 |
4 |
D |
$3.16 |
$136,626 |
D/D |
(43,236) |
354,064 |
|
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2013-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
397,300 |
|
- |
|
| Jones Jess |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
29,250 |
|
- |
|
| Ford Brendan A |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
84,250 |
|
- |
|
| Rowinsky Eric K |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
104,250 |
|
- |
|
| Drake Peter F |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
39,250 |
|
- |
|
| Troup Gordon A |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
89,250 |
|
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2013-02-17 |
4/A |
D |
$3.08 |
$104,948 |
D/D |
(34,074) |
273,226 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-11-27 |
4 |
D |
$2.58 |
$7,744,799 |
D/D |
(3,001,860) |
3,799,156 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-10-10 |
4 |
B |
$2.56 |
$94,797 |
D/D |
37,030 |
6,801,016 |
2.45 |
- |
|
| Rowinsky Eric K |
Director |
• • – |
2012-09-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
92,000 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-21 |
4 |
S |
$3.24 |
$15,912 |
D/D |
(4,911) |
6,763,986 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-19 |
4 |
S |
$3.22 |
$69,874 |
D/D |
(21,700) |
6,768,897 |
|
- |
|
| Tulip Thomas H. |
EVP & Chief Business officer |
• • – |
2012-09-14 |
4 |
B |
$2.70 |
$40,500 |
D/D |
15,000 |
27,500 |
2.44 |
- |
|
| Ford Brendan A |
Director |
• • – |
2012-09-12 |
4 |
B |
$2.64 |
$13,200 |
D/D |
5,000 |
72,000 |
2.81 |
- |
|
| Troup Gordon A |
Director |
• • – |
2012-09-12 |
4 |
B |
$2.64 |
$13,185 |
D/D |
5,000 |
77,000 |
2.81 |
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2012-09-11 |
4 |
B |
$2.64 |
$10,552 |
D/D |
4,000 |
307,300 |
2.81 |
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-10 |
4 |
S |
$3.69 |
$1,072,876 |
D/D |
(290,419) |
6,790,597 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-07 |
4 |
S |
$3.61 |
$428,619 |
D/D |
(118,731) |
7,081,016 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-06 |
4 |
S |
$3.71 |
$8,162 |
D/D |
(2,200) |
7,199,747 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-05 |
4 |
S |
$3.78 |
$245,322 |
D/D |
(64,900) |
7,201,947 |
|
- |
|
411 Records found
|
|
Page 10 of 17 |
|
|
